Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Recruiting now
Conditions studied: Clonal Mast Cell Disease, KIT D816V Mutation, Suspected KITD816V Mutated Clonal Mast Cell Disease
In brief
This is a multicenter screening study to characterize the prevalence of the KIT D816V mutation in participants with suspected clonal mast cell disease.
Key facts
- Study ID
- NCT07143669
- Run by
- Blueprint Medicines Corporation
- People needed
- 450
- Starts
- 2025-10-17
- Expected to finish
- 2028-10-31
- Last updated by the study team
- 2026-06-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- AllerVie Clinical Research — Birmingham, Alabama, United States (enrolling)
- O'Neal Comprehensive Cancer Center at the UAB — Birmingham, Alabama, United States (enrolling)
- Kaiser Permanente San Diego — San Diego, California, United States (enrolling)
- Allergy & Asthma Clinical Research of the Bay Area — Walnut Creek, California, United States (enrolling)
- Allergy, Asthma, & Immunology Associates of Tampa Bay — Tampa, Florida, United States (enrolling)
- Emory University — Atlanta, Georgia, United States (enrolling)
- Northwestern Medicine Allergy and Immunology — Chicago, Illinois, United States (enrolling)
- Midwest Allergy Sinus Asthma — Normal, Illinois, United States (enrolling)
- University of Kansas Medical Center — Kansas City, Kansas, United States (enrolling)
- Tulane University School of Medicine — New Orleans, Louisiana, United States (enrolling)
- AllerVie Health — Glenn Dale, Maryland, United States (enrolling)
- Barnes-Jewish West County Hospital — St Louis, Missouri, United States (enrolling)
- Somnos Clinical Research — Lincoln, Nebraska, United States (enrolling)
- Mount Sinai Hospital — New York, New York, United States (enrolling)
- The University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States (enrolling)
- Allergy, Asthma & Clinical Research Center — Oklahoma City, Oklahoma, United States (enrolling)
- Allergy & Clinical Immunology Associates — Pittsburgh, Pennsylvania, United States (enrolling)
- Care Access Research — Warwick, Rhode Island, United States (enrolling)
- AIR Care — Dallas, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.